AMPH: Amphastar Pharmaceuticals, Inc. Stock

by  •  • Comments Off on AMPH: Amphastar Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,349.45
Enterprise Value ($M) 1,799.71
Book Value ($M) 732.30
Book Value / Share 15.37
Price / Book 1.84
NCAV ($M) -311.10
NCAV / Share -6.53
Price / NCAV -4.34

Profitability (mra)
Return on Invested Capital (ROIC) 0.12
Return on Assets (ROA) 0.11
Return on Equity (ROE) 0.25

Liquidity (mrq)
Quick Ratio 2.19
Current Ratio 3.07

Balance Sheet (mrq) ($M)
Current Assets 534.07
Assets 1,577.47
Liabilities 845.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 731.97
Operating Income 205.42
Net Income 159.52
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 213.39
Cash from Investing -124.93
Cash from Financing -80.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-07 13G/A Zhang Jack Y. 24.80 -6.78
2024-03-06 13G/A Federated Hermes, Inc. 4.52 -33.85
2024-02-13 13G/A Vanguard Group Inc 5.88 7.36

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 97,545 435,947 22.38
2025-03-06 139,268 643,533 21.64
2025-03-05 70,529 499,794 14.11
2025-03-04 128,660 619,789 20.76

(click for more detail)

Similar Companies
ALXO – ALX Oncology Holdings Inc. AMGN – Amgen Inc.
AMLX – Amylyx Pharmaceuticals, Inc. AMRX – Amneal Pharmaceuticals, Inc.
ANAB – AnaptysBio, Inc.


Financial data and stock pages provided by
Fintel.io